Susquehanna International Group’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-12,200
Closed -$126K 13706
2024
Q4
$126K Buy
+12,200
New +$118K ﹤0.01% 11156
2023
Q4
Sell
-18,900
Closed -$170K 13468
2023
Q3
$170K Buy
18,900
+6,800
+56% +$64.6K ﹤0.01% 10422
2023
Q2
$136K Buy
+12,100
New +$107K ﹤0.01% 10672

Other funds holding ENFN

Susquehanna International Group's ENFN Position: Q2 2025 in Review

Susquehanna International Group sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 66,724 shares — an estimated $744K sold.

Susquehanna International Group first reported a position in ENFN in Q4 2021 and held it in 11 quarters. The position peaked at $2.13M in Q4 2024. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • Susquehanna International Group reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 66,724 Enfusion, Inc. shares in Q2 2025, an estimated $744K.
  • Susquehanna International Group first reported a position in Enfusion, Inc. in Q4 2021 and held it in 11 quarters.
  • Susquehanna International Group's Enfusion, Inc. position peaked at $2.13M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.